Stephane Jallat
Finanzdirektor/CFO bei Piramed Ltd.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Michael D. Waterfield | M | - |
Piramed Ltd.
 Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | 21 Jahre |
| Paul Workman | M | 72 |
Piramed Ltd.
Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | 21 Jahre |
| Peter Parker | M | - |
Piramed Ltd.
Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | 21 Jahre |
| Simon Long | M | - |
Piramed Ltd.
Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Michael G. Moore | M | - |
Piramed Ltd.
Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | 5 Jahre |
| Hervé Suquet | M | - |
Université Paris 1 Panthéon-Sorbonne
| 5 Jahre |
| Frédéric Fasano | M | 56 |
ESSEC Business School
| 2 Jahre |
| Serge Touati | M | - |
ESSEC Business School
| 4 Jahre |
| Francis Chiu | M | 61 |
ESSEC Business School
| 2 Jahre |
| Minh Lé | M | - |
ESSEC Business School
| 4 Jahre |
| Anthony Brown | M | - |
Piramed Ltd.
Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | - |
| Thibaut du Fayet | M | 56 |
ESSEC Business School
| 2 Jahre |
| Shi-Yi Yue | M | - |
Université Paris 1 Panthéon-Sorbonne
| 3 Jahre |
| Michael Moryoussef | M | - |
Université Paris 1 Panthéon-Sorbonne
| 5 Jahre |
| Virginie Ducrot | F | - |
ESSEC Business School
| 4 Jahre |
| Giorgos Kaminis | M | 69 |
Université Paris 1 Panthéon-Sorbonne
| 3 Jahre |
| Henriette Wendt | F | 55 |
ESSEC Business School
| 3 Jahre |
| Marion Verges | F | - |
ESSEC Business School
| 4 Jahre |
| Luc Jeanneney | M | 57 |
ESSEC Business School
| 2 Jahre |
| Jean Zetlaoui | M | - |
ESSEC Business School
| 2 Jahre |
| Maria Paublant | F | 55 |
ESSEC Business School
| 4 Jahre |
| Catherine Casamatta | M | 51 |
ESSEC Business School
| 4 Jahre |
| Silvain Desjonquères | M | - |
ESSEC Business School
| 3 Jahre |
| Anne Ramon | F | - |
Université Paris 1 Panthéon-Sorbonne
| 2 Jahre |
| Jean-Philippe Kouakou-Zebouah | M | - |
ESSEC Business School
| 3 Jahre |
| Delphine Descamps | M | - |
Université Paris 1 Panthéon-Sorbonne
| 5 Jahre |
| Alexis Kohler | M | 51 |
ESSEC Business School
| 4 Jahre |
| Nicolas Besse | M | 59 |
ESSEC Business School
| 1 Jahre |
| Philippe Setbon | M | 59 |
Université Paris 1 Panthéon-Sorbonne
| 4 Jahre |
| Jean-Marc Husson | M | - |
Université Paris 1 Panthéon-Sorbonne
| 3 Jahre |
| Emmanuelle Bely | F | 55 |
ESSEC Business School
| 2 Jahre |
| Tim J. Pryce | M | 59 |
Université Paris 1 Panthéon-Sorbonne
| 2 Jahre |
| Frédéric Chéreau | M | 57 |
Université Paris 1 Panthéon-Sorbonne
| 2 Jahre |
| David B. Knowles | M | - |
Piramed Ltd.
Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | - |
| George Kassiotis | M | 50 |
Université Paris 1 Panthéon-Sorbonne
| 4 Jahre |
| Fabrice Paublant | M | - |
ESSEC Business School
| 4 Jahre |
| Didier Centis | M | - |
Université Paris 1 Panthéon-Sorbonne
| 4 Jahre |
| Victoire Jacquin de Margerie | M | 61 |
Université Paris 1 Panthéon-Sorbonne
| 3 Jahre |
| Stephen Shuttleworth | M | - |
Piramed Ltd.
Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | 3 Jahre |
| Nathalie Debeir | F | 56 |
Université Paris 1 Panthéon-Sorbonne
| 3 Jahre |
| Neil Pegg | M | - |
Piramed Ltd.
Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | - |
| Olivier Theulle | M | - |
ESSEC Business School
| 3 Jahre |
| Vincent Tarantino | M | - |
Université Paris 1 Panthéon-Sorbonne
| 1 Jahre |
| Rosaura P. C. Valle | M | - |
Université Paris 1 Panthéon-Sorbonne
| 3 Jahre |
| Christine Chavany | M | - |
Université Paris 1 Panthéon-Sorbonne
| 3 Jahre |
| Ismaïl Fassi-Fihri | M | - |
Université Paris 1 Panthéon-Sorbonne
| 1 Jahre |
| Arnaldo Penteado Laudisio | M | 60 |
Université Paris 1 Panthéon-Sorbonne
| 1 Jahre |
| Girindre Beeharry | M | - |
Université Paris 1 Panthéon-Sorbonne
| 3 Jahre |
| Hervé Alexandre | M | 62 |
Université Paris 1 Panthéon-Sorbonne
| 3 Jahre |
| Gui Sheng Li | M | 70 |
Université Paris 1 Panthéon-Sorbonne
| 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Frankreich | 41 | 82,00% |
| Vereinigtes Königreich | 9 | 18,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Stephane Jallat
- Persönliches Netzwerk
